# EDGAR Filing Document

**Accession Number:** 0002023016
**File Stem:** 0001104659-25-097622
**Filing Date:** 2025-10
**Character Count:** 8450
**Document Hash:** 821b9f2b95c985593fac6fb0b9ebf074
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-097622.hdr.sgml**: 20251007

**ACCESSION NUMBER**: 0001104659-25-097622

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251007

**FILED AS OF DATE**: 20251007

**DATE AS OF CHANGE**: 20251007

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Kester Kent Edward
- **CENTRAL INDEX KEY:** 0002087469

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42875
- **FILM NUMBER:** 251381007

**MAIL ADDRESS:**
- **STREET 1:** 250 N. WESTLAKE BLVD
- **STREET 2:** STE 210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Turn Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0002023016
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 320456090
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 250 NORTH WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362
- **BUSINESS PHONE:** 8185644011

**MAIL ADDRESS:**
- **STREET 1:** 250 N. WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Global Health Solutions, Inc
- **DATE OF NAME CHANGE:** 20240510

## Ex-24

**Exhibit 24**

**POWER OF ATTORNEY**

The undersigned hereby appoints and authorizes each of:

&nbsp;&nbsp;&nbsp;&nbsp;· Chief Executive Officer of Global Health Solutions Inc. (dba Turn Therapeutics) (hereinafter referred
to as the "Company") who is currently Bradley E. Burnam or their successor; and

&nbsp;&nbsp;&nbsp;&nbsp;· Interim Chief Financial Officer, Vice President of Finance and Chief Accounting Officer, who is currently
Zuraiz Chaudhary or their successor

as the undersigned's true and lawful attorney-in-fact, each with full power of substitution and full power to act alone, to:

&nbsp;&nbsp;&nbsp;&nbsp;1. prepare and sign in the name of and on behalf of the undersigned any and all forms and reports required
to be filed pursuant to the Exchange Act of 1933 and the Securities Exchange Act of 1934 and the rules and regulations thereunder,
including, but without limitation, Forms 3, 4 and 5, Schedule 13D/G, other necessary filings under Section 16(a) of the securities
Exchange Act of 1934 and the rules and regulations thereunder and Form ID if needed and Uniform Application for Access Codes
to File on EDGAR;

&nbsp;&nbsp;&nbsp;&nbsp;2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable
to complete and execute any such forms and filings, and timely file such forms with the United States Securities and Exchange Commission;

&nbsp;&nbsp;&nbsp;&nbsp;3. seek or obtain, as the undersigned's representative and on the undersigned's behalf, information regarding
transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such release of information; and

&nbsp;&nbsp;&nbsp;&nbsp;4. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution (including appointing substitutes for themselves, for each other and for any successor to any attorney-in-fact hereunder) or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

This Limited Power of Attorney shall remain in effect until the undersigned is no longer required to file forms with respect to the securities of the Company, unless earlier revoked by the undersigned in a signed and dated writing delivered to the foregoing attorney-in-fact.

[Signature Page Follows]

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as September 29, 2025.

---

| | |
|:---|:---|
| Name: | Kent Kester |
| Signature: | /s/ Kent Kester |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Kester Kent Edward<br><sub>(Last) (First) (Middle)</sub><br>C/O TURN THERAPEUTICS INC.<br>250 N. WESTLAKE BLVD.<br><sub>(Street)</sub><br>WESTLAKE VILLAGE, CA 91362<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Turn Therapeutics Inc. [ TTRX ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-10-07 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | <sup>(1)</sup> | 2034-08-12 | Common Stock | 40030<sup>(2)</sup> | 4.59<sup>(2)</sup> | D |  |

---

### Footnotes:

(1) The stock option became exercisable as to 11,716 of the shares of common stock on August 12, 2024, and 858 shares on the last day of each month thereafter, in each case, after giving effect to the stock split as described below.

(2) The number of shares of common stock underlying the stock option and the applicable exercise price give effect to the 2-for-1 forward stock split, that took effect on September 30, 2025.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Zuraiz Chaudhary, attorney-in-fact for Kent Kester  
**Date:** 2025-10-07

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**